Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis-Reference-Cited by-同舟云学术

Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis

Published:2023-06 Issue:6 Volume:29 Page:599-606
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Marshall Landon Z¹,Espinosa Rachel¹,Starner Catherine I¹,Gleason Patrick P¹

Affiliation:

1. Prime Therapeutics Eagan, MN.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference20 articles.

1. Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators

2. The pathology of cystic fibrosis

3. Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population

4. Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “I eat chocolate milk for dinner because we just have nothing in our fridge”: The invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States;Pediatric Pulmonology;2024-07-23

2. Unmet challenges in cystic fibrosis treatment with modulators;Expert Review of Respiratory Medicine;2024-04-02

3. PTI-801 (posenacaftor) shares a common mechanism with VX-445 (elexacaftor) to rescue p.Phe508del-CFTR;European Journal of Pharmacology;2024-03

4. Pharmacokinetic Enhancement of Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: A Cost Reduction Strategy to Address Global Disparities in Access;Clinical Pharmacology & Therapeutics;2024-02-22

5. Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor;Molecules;2024-02-10